InhaleRx (ASX:IRX) Days Payable : 0.00 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Days Payable?

InhaleRx's average Accounts Payable for the six months ended in Jun. 2023 was A$0.25 Mil. InhaleRx's Cost of Goods Sold for the six months ended in Jun. 2023 was A$0.00 Mil.

The historical rank and industry rank for InhaleRx's Days Payable or its related term are showing as below:

During the past 7 years, InhaleRx's highest Days Payable was 314.22. The lowest was 186.82. And the median was 250.52.

ASX:IRX's Days Payable is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 73.105
* Ranked among companies with meaningful Days Payable only.

InhaleRx's Days Payable stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00).

InhaleRx Days Payable Historical Data

The historical data trend for InhaleRx's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Days Payable Chart

InhaleRx Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

186.82

314.22

InhaleRx Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of InhaleRx's Days Payable

For the Medical Devices subindustry, InhaleRx's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InhaleRx's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InhaleRx's Days Payable distribution charts can be found below:

* The bar in red indicates where InhaleRx's Days Payable falls into.

InhaleRx Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

InhaleRx's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.123	+	0.184)	/	2 )	/	0	*	365
=	0.1535					/	0	*	365
=	N/A

InhaleRx's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0.123	+	0.372)	/	2 )	/	0	*	365 / 2
=	0.2475					/	0	*	365 / 2
=	N/A

InhaleRx Days Payable Related Terms

Thank you for viewing the detailed overview of InhaleRx's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx (ASX:IRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines